EB-3D

N/A

Report date: 2023/04/03 14:31:04
NME

Base Information

Drug NameEB-3D
Drug Alias NameEB-3-D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholine kinase alpha inhibitors
TargetsCholine kinase alpha
Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Padova
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Padova
Inactive CompaniesN/A
Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A